Transce3nd’s Johnson & Johnson JNJ Stock Holding History

Transce3nd’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-511	Closed	-$78K	–	690
2025 Q2	$78K	Sell	511 -36	-7%	-$5.53K	0.03%	226
2025 Q1	$90.7K	Sell	547 -579	-51%	-$90.6K	0.04%	205
2024 Q4	$163K	Buy	+1,126	New	+$174K	0.06%	191

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Transce3nd's JNJ Position: Q3 2025 in Review

Transce3nd sold out of Johnson & Johnson (JNJ) in Q3 2025, closing a stake of 511 shares — an estimated $78K sold.

Transce3nd first reported a position in JNJ in Q4 2024 and held it in 3 quarters. The position peaked at $163K in Q4 2024. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

Transce3nd reported no remaining Johnson & Johnson position as of Q3 2025 after selling out during the quarter.
Transce3nd sold 511 Johnson & Johnson shares in Q3 2025, an estimated $78K.
Transce3nd first reported a position in Johnson & Johnson in Q4 2024 and held it in 3 quarters.
Transce3nd's Johnson & Johnson position peaked at $163K in Q4 2024.
4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.